Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 10OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 10Head and Neck Neoplasms 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Central Nervous System Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Breast Neoplasms 2Astrocytoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1

Interventions

Radiotherapy 13Temozolomide 12Carmustine 5Chemotherapy, Adjuvant 3Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2Bevacizumab 2veliparib 1vatalanib 1sagopilone 1rubitecan 1mercaptoundecahydrododecaborate 1lonafarnib 1imetelstat 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Proton Therapy 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Microarray Analysis 1Methotrexate 1Lomustine 1Leucovorin 1Irinotecan 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gliosarcoma × Radiotherapy, Conformal × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡